NCT00549510View on ClinicalTrials.gov

Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

PHASE1CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Hypertension

Interventions

DRUG

COREG CR and lisinopril (FDC)

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY